Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Brown is the vice president of medical affairs and patient advocacy at Southern Research and project lead for Catalyst. Sodeke is the resident bioethicist and professor of bioethics at the Center for ...

The UK’s National Health Service (NHS) has been awarded £47.8m ($63.8m) from the National Institute for Health and Care Research (NIHR) to pay for equipment that will increase the NHS’s ability to ...

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...

A novel approach has identified drugs in current use that could be repurposed for treating alcohol use disorder (AUD). In 2023, 28 million US adults had experienced AUD in the past year. But only ...

Fayetteville patients will soon have expanded access to advanced cancer treatments through a new oncology clinical trial ...

Pritchard worked in the Office for Human Research Protections for 20 years and retired as the senior adviser to the director of OHRP in 2024. Deciding whether to participate in a clinical research ...

IQVIA Holdings Inc. (NYSE:IQV) is one of the 11 Best Affordable Growth Stocks to Buy Now. On March 3, analysts at RBC Capital initiated coverage of IQVIA Holdings Inc. (NYSE:IQV) with an Outperform ...

UMN Hormel Institute study: grass-fed regenerative organic beef improved cholesterol, triglycerides and inflammation markers vs conventional, earning national research award finalist status.

Annual campaign honors the people who power clinical research and medical progress, with industry partners joining in support ...